These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 26247255

  • 21. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
    Schmitt C, Doret M, Massardier J, Hajri T, Schott AM, Raudrant D, Golfier F.
    Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
    [Abstract] [Full Text] [Related]

  • 22. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
    Dantas PRS, Maestá I, Filho JR, Junior JA, Elias KM, Howoritz N, Braga A, Berkowitz RS.
    Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
    [Abstract] [Full Text] [Related]

  • 23. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
    Asmar FTC, Braga-Neto AR, de Rezende-Filho J, Villas-Boas JMS, Charry RC, Maesta I.
    Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
    [Abstract] [Full Text] [Related]

  • 24. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 25. Human Chorionic Gonadotropin Regression Curves after Partial or Complete Molar Pregnancy in Flanders: Are They Different from Regression Curves from the Eighties?
    Delattre S, Han S, Moerman P, Billen J, Goffin F, Scharpé K, Vergote I.
    Gynecol Obstet Invest; 2018 Jul; 83(1):76-82. PubMed ID: 28329740
    [Abstract] [Full Text] [Related]

  • 26. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
    Feltmate CM, Growdon WB, Wolfberg AJ, Goldstein DP, Genest DR, Chinchilla ME, Lieberman ES, Berkowitz RS.
    J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
    [Abstract] [Full Text] [Related]

  • 27. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M, Kane-Gueye SM, Ndiaye-Gueye MD, Mbaye M, Diouf AA, Niang MM, Diallo M, Moreau JC.
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [Abstract] [Full Text] [Related]

  • 28. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
    Braga A, Maestá I, Rocha Soares R, Elias KM, Custódio Domingues MA, Barbisan LF, Berkowitz RS.
    Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
    [Abstract] [Full Text] [Related]

  • 29. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A, Maestá I, Short D, Savage P, Harvey R, Seckl MJ.
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [Abstract] [Full Text] [Related]

  • 30. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC.
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW, Cho H, Kim H, Nam EJ, Kim SW, Kim S, Kim YT, Kim JH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [Abstract] [Full Text] [Related]

  • 33. Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement.
    Hoeijmakers YM, Eysbouts YK, Massuger LFAG, Dandis R, Inthout J, van Trommel NE, Ottevanger PB, Thomas CMG, Sweep FCGJ.
    Gynecol Oncol; 2021 Dec; 163(3):531-537. PubMed ID: 34602288
    [Abstract] [Full Text] [Related]

  • 34. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 35. Trophoblastic disease.
    Ngan HY, Kohorn EI, Cole LA, Kurman RJ, Kim SJ, Lurain JR, Seckl MJ, Sasaki S, Soper JT.
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 2():S130-6. PubMed ID: 22999504
    [No Abstract] [Full Text] [Related]

  • 36. Persistent mild increase of human chorionic gonadotropin levels in a 31-year-old woman after spontaneous abortion.
    Chen J, Samson SL, Bentley J, Chen Y.
    CMAJ; 2016 Dec 06; 188(17-18):E504-E508. PubMed ID: 27698202
    [No Abstract] [Full Text] [Related]

  • 37. Gestational trophoblastic disease.
    Seckl MJ, Sebire NJ, Berkowitz RS.
    Lancet; 2010 Aug 28; 376(9742):717-29. PubMed ID: 20673583
    [Abstract] [Full Text] [Related]

  • 38. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.
    Obstet Gynecol; 2006 Mar 28; 107(3):743. PubMed ID: 16507954
    [No Abstract] [Full Text] [Related]

  • 39. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-Analysis.
    Sanchez-Ramos L.
    Obstet Gynecol; 2020 May 28; 135(5):1225-1226. PubMed ID: 32332394
    [No Abstract] [Full Text] [Related]

  • 40. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
    Mayfield J, Fleischman A, Melvin J, Knittel A.
    Obstet Gynecol; 2020 May 28; 135(5):1226. PubMed ID: 32332395
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.